This documentation provides confidence that reactions, if they occur, relate to the peptide rather than manufacturing defects
Although there are currently limited studies on GLUT3-targeted anti-tumor therapy, its higher affinity for glucose, relatively specific distribution in tumor cells, and greater sensitivity to tumors in a low-glucose microenvironment (such as the necrotic area) endow GLUT3-targeted anti-tumor therapy with a more promising therapeutic prospect, especially for glioblastoma, brain metastases, and chemotherapy-resistant tumors
(2) the half-life of the compound must be of sufficient duration to maintain a therapeutic level
The choice between them depends on your weight loss goals, side effect tolerance, and physician recommendation
This helps reduce blood sugar spikes